Your browser doesn't support javascript.
loading
Razumab -- the role of biosimilars for the treatment of retinal diseases.
Ferro Desideri, L; Cutolo, C A; Traverso, C E; Nicolò, M.
Affiliation
  • Ferro Desideri L; University Eye Clinic of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. lorenzoferrodes@gmail.com.
  • Cutolo CA; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
  • Traverso CE; University Eye Clinic of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Nicolò M; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy.
Drugs Today (Barc) ; 57(8): 499-505, 2021 Aug.
Article in En | MEDLINE | ID: mdl-34405207
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Biosimilar Pharmaceuticals Type of study: Clinical_trials Limits: Humans Language: En Journal: Drugs Today (Barc) Journal subject: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Year: 2021 Document type: Article Affiliation country: Italia Country of publication: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Biosimilar Pharmaceuticals Type of study: Clinical_trials Limits: Humans Language: En Journal: Drugs Today (Barc) Journal subject: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Year: 2021 Document type: Article Affiliation country: Italia Country of publication: España